학술논문
Treatment outcome of patients with diffuse large B-cell lymphoma (DLBCL) in routine care who received standard chemoimmunotherapy with MabThera (R) compared to patients treated with a rituximab biosimilar in first line therapy
Document Type
Journal
Author
Weide, R.; Burkhard, O.; Steinmetz, T.; Schnell, R.; Vehling-Kaiser, U.; Koenigsmann, M.; Ehscheidt, P.; Mueller, L.; Otremba, B.; Wierecky, J.; Tamm, I; Hensel, M.; Knoblich, J.; Feiten, S.; Chakupurakal, G.; Friesenhahn, V; Kleboth, K.; Koepper, H.; Lutschkin, J.; Lutz, C.; Thomalla, J.; van Roye, C.; Heymanns, J.
Source
Subject
Language
English
ISSN
22965262